Microsoft word - preventive medications for columbia university hdhp final 11 7 _2_.docx

Preventive Medications for Columbia University HDHP* -Thyroid Prescriptions -Immunosuppressant Agents  azathioprine (Imuran)  cyclosporine (Sandimmune)  cyclosporine, modified (Gengraf, Neoral)  mycophenolate mofetil (CellCept)  mycophenolic acid (Myfortic)  sirolimus (Rapamune)  tacrolimus (Prograf)
-Hepatitis C Prescriptions

-Heart disease and stroke
o Over-the-counter aspirin medicines, 81 mg or 325 mg o Warfarin (Coumadin, Jantoven) o Heparin and low-molecular-weight heparin: [enoxaparin (Lovenox); fondaparinux o ACE inhibitors and combinations: benazepril (Lotensin, Lotensin HCT); enalapril (Vasotec, Vaseretic); fosinopril (Monopril, Monopril-HCT); lisinopril (Prinivil, Prinzide, Zestril, Zestoretic); quinapril (Accupril, Accuretic); ramipril (Altace) o ACE receptor blockers and combinations: candesartan (Atacand, Atacand HCT); eprosartan (Teveten, Teveten HCT); irbesartan (Avapro, Avalide); losartan (Cozaar, Hyzaar); telmisartan (Micardis, Micardis HCT); valsartan (Diovan, Diovan HCT) o Beta blockers and combinations: atenolol (Tenormin, Tenoretic); bisoprolol (Zebeta, Ziac); metoprolol (Lopressor, Toprol-XL); nebivolol (Bystolic™); propranolol (Inderaol LA, InnoPral XL) o Calcium channel blockers: amlodipine (Norvasc); diltiazem (Cardizem, Cartia XT, Tiazac); nifedipine (Adalat, Procardia); nisoldipine (Sular); verapramil (Calan, Covera-HS, Isoptin SR, Verelan) o Diuretics and combinations: amiloride (Midamor); hydrochlorothiazide; indapamide; metolazone (Zaroxolyn); spironolactone (Aldactone); terazosin (Hytrin); triamterene-HCTZ (Dyazide, Maxzide) o Miscellaneous medicines and combinations: aliskiren (Tekturna); carvedilol (Coreg); clonidine (Catapres, Combipres, Clorpres); doxazosin (Cardura); enalapril-felodipine; hydralazine (Apresoline); amlodipine/benazepril (Lotrel); amlodipine/valsartan (Exforge) o HMG-coA reductase inhibitors: atorvastatin (Lipitor); lovastatin (Mevacor, Altoprev); pravastatin (Pravachol); rosuvastatin (Crestor); simvastatin (Zocor) o Other agents: cholestyramine (Prevalite, Questran); colesevelam (WelChol); colestipol (Colestid); gemfibrozil (Lopid); fenofibrate (Fenoglide™, Lipofen, TriCor); ezetimibe (Zetia); exetimibe/simvastatin (Vytorin); omega-3-acid ethyl esters (Omacor) o niacin (Niacor, Niaspan); niacin/lovastatin (Advicor); niacin ER/simvastatin  montelukast (Singulair)  zafirlukast (Accolate)  zileutron (Zyflo CR)  alendronate (Fosamax, Fosamx Plus D)  calcitonin (Fortical, Miacalcin)  ibandronate (Boniva)  raloxifene (Evista)  risedronate (Actonel)  zoledronic acid (Reclast)  aspart (NovoLog)  detemir (Levemir)  glargine (Lantus)  glulisine (Apidra)  lispro (Humalog)  insulin (Humulin, Novolin)  exenatide (Byetta)  glimepiride (Amaryl)  glipizide and combinations (Glucotrol, Metaglip)  glyburide and combinations (DiaBeta, Glynase, Glucovance)  liraglutide (Victoza)  metformin (Fortamet, Glucophage, Glumetza™)  nateglinide (Starlix)  pioglitazone and combinations (Actos, Duetact™, ACTOplus met)  repaglinide (Prandin)  rosiglitazone and combinations (Avandia, Avandaryl™, Avandamet)  saxagliptin (Onglyza™)  sitagliptin and combinations (Januvia™, Janumet™)
Medco Health Solutions, Inc., is the company that manages the prescription drug benefit for your
employer or health plan.
Please note: Brand names are shown in italics in each category.
All rights in the product names of all third-party products appearing here, whether or not appearing with
the trademark symbol, belong exclusively to their respective owners.


Amberlyst 15 wet -- technical data sheet

AMBERLYST™ 15WET Industrial Grade Strongly Acidic Catalyst For Catalysis and Separation technologies Description AMBERLYST 15WET is a strongly acidic, sulfonic acid, macroreticular polymeric resin based on crosslinked styrene divinylbenzene copolymers. Its continuous open pore structure and excellent physical, thermal and chemical stability makes it the resin of choice in many applica

Ip competition interface paper

North American Developments in the Interface Between Intellectual Property and Competition Law SUSAN HUTTON AND ALEXANDRA STOCKWELL STIKEMAN ELLIOTT LLP │ MONTRÉAL TORONTO OTTAWA CALGARY VANCOUVER NEW YORK LONDON SYDNEY www North American Developments in the Interface Between Intellectual Property and Competition Law SUSAN M. HUTTON ([email protected]) AND ALEXANDRA STO

Copyright © 2010-2014 Medical Articles